{"name":"Franco Locatelli","slug":"franco-locatelli","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxPRmdIbGRUQkFWRmlFMnh3bnpyMzRsNVQ1cGhMQXJ1alltYkt4YlF3UGx4bTJnSUZicGtKUEdhRFAyamhRbnpSVmxWbW9ueUxwT2hVZFlDTGhRQUptc1BPLUJJSE1jTTctVlNYSF9USkxCLVRJaVpHSTYzeXV2RUROR3g5SUtoV1hBQi1CTzM1c29ZX1pOMGIwbVNpbjhRbjRJbWd3bU96SXFWenVjZVR4M1ZGa2hGTHowM1N2M0hCbGZWRThXVkpGLUtYakpWQUNxM0ZUZWRsSQ?oc=5","date":"2025-09-16","type":"pipeline","source":"pharmaceutical-journal.com","summary":"Putting the spotlight back on haemoglobinopathies: the emergence of specialist pharmacists - pharmaceutical-journal.com","headline":"Putting the spotlight back on haemoglobinopathies: the emergence of specialist pharmacists - pharmaceutical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQNnFFblQ1d0diTGU0eU9vOTZRSmhIY3Q2QWV2cEJnV3REWllmMnM4eFh5bThpYlF0TTdNZ0UwQ0NEQ255T0syRmVFZGxIWV9hTk5uTGZvUzRVOTVaMFQzM29RQTVmZHl2aDdHRVVxb1lsZ0xlUlgzZ1RTcXFuLTE4S2E3U0xBTl9qdTh1dnBfMUhOem9PU1Br?oc=5","date":"2025-09-15","type":"pipeline","source":"Medscape","summary":"Beta Thalassemia: Gene Editing Enhances QOL - Medscape","headline":"Beta Thalassemia: Gene Editing Enhances QOL","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQb2htc2RkNkU3UWo0dFc3RDRCd3BqdDRoQjJ2VG5FOVZ4dV84V2t5ckk3SUpGcnVnVTZNRW5JNkV6STdZSEpvMnRyLVc2ajhnRFB4dXpTUDBYbkpyeXExMk5VZGdxUkFMS1JiMHFfOTJRWWxPck95QVdEdVA1T21wLXY4WXNGTDRJRGFPX2xVaW15VDVHa1NsZGZOUXVSc0ozWjJldFBGSUs?oc=5","date":"2025-06-18","type":"pipeline","source":"PMLiVE","summary":"AstraZeneca’s Ultomiris shows promise in rare post-transplant complication - PMLiVE","headline":"AstraZeneca’s Ultomiris shows promise in rare post-transplant complication","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOclVUU2FQcEgzX1ZNSFZRbmhjRlRIdy1rMENDYWdiZ196N25SN29jNUNCOFIwUXFhQzlzSndpZ05yTFlPQWd0X05Lc1pJS05oVTVPLWNQTVFvbDdkRXZSOFc5QkhWSkF4Y3VmVUdmbWR3bnVOS3QyVnVEcjhEaFVudEVqVlV4czJDa1kxSkxpYWhJUmJ6djY4dFVUcG1PMmNpQUlaMGdaODRWcHIwTjc2eXlJcXdpdGZpbGVYWA?oc=5","date":"2025-06-16","type":"trial","source":"Fierce Pharma","summary":"AstraZeneca touts early Ultomiris survival data in children living with rare post-transplant complication - Fierce Pharma","headline":"AstraZeneca touts early Ultomiris survival data in children living with rare post-transplant complication","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOZ0JzOEN4cEFvLUxyMHp5ODRZVEZlbUROZER2WlRmRjRNV2VucXJJa2NrbUMtd1Q5YnZLN2RZMThFSzVfd29aSlV4YWNXOGNCeTJ4U2N0TkY5dWExMDFkTm5vV1NJYmQtWjVFMjV1cEpNRTJqb2hPNVRLREptR2hJTENKWGdHSGh0MkZVSzRSeHpfejVBZ25YVW9TbnZ6RTJSTmc?oc=5","date":"2025-04-11","type":"pipeline","source":"European Medical Journal","summary":"EBMT 2025 Interview: Luigi Naldini and Franco Locatelli - European Medical Journal","headline":"EBMT 2025 Interview: Luigi Naldini and Franco Locatelli","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPTnh5bmY0aE9MeUl1ZTdsbGlPaFgyZkRnQnVYWHVlUHVaSkVqY2lUeHlsRDFiM094WkFVeGZXWkd6TEZ3eVp6VF9QOEVqdzBJZmhkQ0diVkx1Z3M0ZjU4RGNZanNGNkdGeG1HUUxNNmVvdmhZRlpkNW5aS0NjTVIya1RKMlN5Yzl4ODRmaXk2NXc5aDR2enZZeGpFZ2JMWVhfVTNxLWMtRVdZeXNEOU1YekY5NjFOVTYw?oc=5","date":"2024-11-01","type":"pipeline","source":"pharmaphorum","summary":"The 8th CAR-TCR Summit Europe: Your European Hub of Next Generation Cell Therapy Innovation - pharmaphorum","headline":"The 8th CAR-TCR Summit Europe: Your European Hub of Next Generation Cell Therapy Innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOcXFfYXFiWklvVEc0ank4SXhkdnVGZ18wVThZdnBGYU9uUFRqOEgwVkZ4TWRaajlIT0Zodks5alBYUkZENzB0a0lpVHVkZ1FJVGJVWWtrV2JpbEVWT1JrX3pYSGdPd2lPY1pha0RiSldlN3pDdjBfbDF3NUxjYTVWX1QtR05udFozcnRLZnJtZGMydGF6YUx4TUthRXNFUGJUTkZWS2diNnZjOTY1T2txcTlfSlhuZG8?oc=5","date":"2024-02-13","type":"regulatory","source":"European Pharmaceutical Review","summary":"Vertex secures European approval for CRISPR cell therapy - European Pharmaceutical Review","headline":"Vertex secures European approval for CRISPR cell therapy","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE5ESWtkcDY2LUlmaVRhRkN4UHBSMmZkNTN2M2hJdlItS1pVVlZRc3BoalVIVTVxNWNkT01LTmJYQTBwSTdPQlA0OWJ5cW1wZG04cFZ4b0VQY3F2alZuTHBuTFhOYjB6T1pC?oc=5","date":"2023-12-15","type":"trial","source":"Wiley Online Library","summary":"Defining curative endpoints for transfusion-dependent β-thalassemia in the era of gene therapy and gene editing - Wiley Online Library","headline":"Defining curative endpoints for transfusion-dependent β-thalassemia in the era of gene therapy and gene editing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTFBhNHZVczRfaHJ4bndTalpBeW1lVm5SVjJSdVUzSU1zMVo2NVZPRkVkZEhNQ0RMeUtzSVlfQUxUMDlncVdEU1lCc0lSSkxtU0Nzd3FqTDF4ZG9RZEozdkFqOFdHdmNMMUQ0?oc=5","date":"2023-11-27","type":"trial","source":"Wiley Online Library","summary":"Defining curative endpoints for sickle cell disease in the era of gene therapy and gene editing - Wiley Online Library","headline":"Defining curative endpoints for sickle cell disease in the era of gene therapy and gene editing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTFBQVFpVRl95VlBfSVhha01Kel9BRWdvanBlNkhlMGxuQlhWeTE1b19jTm9fS0pUNU02VlV2cjNYWUpPM2phNFA5Nnc4MVJXNkwyRzVOaGNqOVM1QmViT2dCT0xQWl85emQtWjlWcmplRzRScjJUckE?oc=5","date":"2023-04-06","type":"pipeline","source":"MedPage Today","summary":"CAR T-Cell Therapy Feasible, Safe in Advanced Neuroblastoma - MedPage Today","headline":"CAR T-Cell Therapy Feasible, Safe in Advanced Neuroblastoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTFBfSmZqR3B0TUlKcm9mSWpPTmMzVF9JX3NDQloxV3JsMnBKaWFtLVRHc1F3cjdoMVd3Mml4S3dNeXktbFQ4M1dVTUVYVXZtOWk3YTZDc29SZW5BODlFVGxhSg?oc=5","date":"2023-04-05","type":"pipeline","source":"NEJM","summary":"GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma - NEJM","headline":"GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQdVdaanVGTkR4b3Z5MUdJdFgtQ1FvelRITDJmb203eVA3RUtObkhULV83ZW5FVHVOYVBIbVM0NmNjaEVjRHpIWEZHcEtIUkZLV09iRm5fNk95R3QwaW5OQWNVeUo0bTY5X1lDQmFMVmxWZzZzTW9iSHptXzRvdlRwLXZCMU9kaGFKUXExaGFiRk0wR3pVamlLYm11dGQxY1JXbG0zbEZQZTUzd0RObFkwWkFFZmxkYVpMTk1aaGUyT0Q?oc=5","date":"2021-03-05","type":"pipeline","source":"Healio","summary":"Blinatumomab shows benefit in pediatric B-cell ALL in first relapse - Healio","headline":"Blinatumomab shows benefit in pediatric B-cell ALL in first relapse","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}